Scarica l'app Stockscreener
428.81
3.33%
13.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$414.98
Aprire:
$416.5
Volume 24 ore:
318.79K
Relative Volume:
0.16
Capitalizzazione di mercato:
$51.49B
Reddito:
$137.20B
Utile/perdita netta:
$1.15B
Rapporto P/E:
45.89
EPS:
9.3439
Flusso di cassa netto:
$1.27B
1 W Prestazione:
+2.01%
1M Prestazione:
+11.03%
6M Prestazione:
+103.87%
1 anno Prestazione:
+50.99%
Intervallo 1D:
$416.50
$429.31
Intervallo di 1 settimana:
$407.50
$437.70
Portata 52W:
$163.11
$456.50
Humana Inc Stock (HUM) Company Profile
Nome
Humana Inc
Settore
Industria
Telefono
(502) 580-1000
Indirizzo
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
428.82 | 51.49B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
421.31 | 378.16B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.35 | 120.67B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
438.85 | 95.17B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
305.49 | 80.72B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2026-10-09 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2026-10-07 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2026-09-25 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2026-08-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2026-07-30 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2026-07-30 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2026-07-30 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-07-29 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2026-07-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-05-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-02-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-14 | Iniziato | Goldman | Sell |
| 2025-09-22 | Iniziato | Evercore ISI | In-line |
| 2025-05-01 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-10-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-03-22 | Iniziato | Raymond James | Mkt Perform |
| 2024-03-13 | Downgrade | Argus | Buy → Hold |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-01-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Aggiornamento | Argus | Hold → Buy |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Downgrade | Argus | Buy → Hold |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-10-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Iniziato | Bernstein | Mkt Perform |
| 2022-04-13 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-04 | Reiterato | Barclays | Overweight |
| 2021-11-04 | Reiterato | Credit Suisse | Outperform |
| 2021-11-04 | Reiterato | Morgan Stanley | Overweight |
| 2021-11-04 | Reiterato | Oppenheimer | Outperform |
| 2021-11-04 | Reiterato | RBC Capital Mkts | Outperform |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-09-09 | Ripresa | Barclays | Overweight |
| 2021-07-09 | Iniziato | Seaport Global Securities | Neutral |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-01-04 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Iniziato | Bernstein | Mkt Perform |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-16 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-06-05 | Iniziato | Goldman | Buy |
| 2020-01-03 | Reiterato | JP Morgan | Overweight |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Iniziato | UBS | Neutral |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Reiterato | BofA/Merrill | Buy |
| 2018-09-13 | Iniziato | Barclays | Overweight |
| 2018-07-12 | Ripresa | Morgan Stanley | Overweight |
| 2018-07-06 | Reiterato | Piper Jaffray | Overweight |
| 2018-06-01 | Ripresa | Citigroup | Buy |
| 2018-02-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Reiterato | Leerink Partners | Outperform |
| 2018-01-12 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Humana Inc Borsa (HUM) Ultime notizie
Lobbying Update: $1,520,000 of HUMANA INC lobbying was just disclosed - Quiver Quantitative
Humana Inc. $HUM Stock: Howard Capital Management LLC Reduces Stake - MarketBeat
Humana Inc. (NYSE:HUM) Stock Has Average Price Target of $453.30 According to Analysts - MarketBeat
A Look at Humana Inc (HUM) After 4.4% Decline -- GF Value $382.9 - GuruFocus
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana Inc. $HUM Position Lifted by Assenagon Asset Management S.A. - MarketBeat
Best Medicare Advantage Plans in 2026 - NerdWallet
Humana vs. UnitedHealthcare Medicare Advantage: Updated for 2027 - NerdWallet
Best Medicare Advantage Dental Insurance for Seniors: Updated for 2027 - NerdWallet
Humana Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Humana Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Humana Will Drop 37 PPOs for 2027. If Her Plan Is Discontinued, She Can Get a Medigap Window Without Health Questions Even if Humana Offers Another Advantage Plan - Yahoo Finance
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? - Zacks Investment Research
Humana Inc. Stock Grades | HUM - Barron's
Humana Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Humana Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
What Humana’s BlackRock Deal, Village Medical’s Divestitures Signal For Older Adult Primary Care - Home Health Care News
Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital - Zacks Investment Research
Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital - Yahoo Finance
Humana (HUM) Will Have 95% of Its Members in Four-Star Plans, Up From 20%. What Changed? - Yahoo Finance
BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion - STAT
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - TradingView
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Humana taps new partner for $2.8B primary care deal - The Business Journals
Humana taps BlackRock as WCAS replacement in CenterWell deal - Modern Healthcare
Perpetual Ltd Sells 10,384 Shares of Humana Inc. $HUM - MarketBeat
BlackRock Will Manage Humana’s CenterWell Clinics In New $2.8 Billion Partnership - Yahoo Finance
Humana expects major liability reduction on new BlackRock clinic JV (HUM:NYSE) - Seeking Alpha
Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics - Yahoo Finance
Humana strikes $2.8 billion BlackRock clinic venture deal - Reuters
Humana forms new clinic joint venture with BlackRock unit - StreetInsider
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates - Zacks Investment Research
Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026 - Yahoo Finance
Humana leads Managed Care winners in new CMS Star RatingsEvercore - Yahoo Finance
Humana leads Managed Care winners in new CMS Star RatingsEvercore - StreetInsider
Humana (HUM) Gets a Major Ratings Boost. Can Earnings Justify the Valuation? - Yahoo Finance
Humana Inc (HUM.SG) stock price, news, quote and history - Yahoo Finance UK
Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength? - Zacks Investment Research
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test - Benzinga
Humana Hits 95% Four-Star Coverage: What it Means for HUM - Yahoo Finance Australia
Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027 - Humana
Humana Inc Stock (HUM) Moved Up by 12.68% on Oct 9: Drivers Behind the Movement - TradingKey
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Yahoo Finance
Humana surges after topping 2027 Medicare star ratings - CNBC
Humana Surges on Medicare Quality Ratings Improvement - Bloomberg.com
S&P 500 Futures Rise in Premarket Trading; Lennar, Humana Lead - Barron's
Humana Says 95% of Medicare Advantage Members in 4-Star Plans for 2027 - WSJ
Humana surges after topping 2027 Medicare star ratings - Reuters
Humana Inc Azioni (HUM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Humana Inc Azioni (HUM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
3.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):